| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:52:00 UTC |
|---|
| HMDB ID | HMDB0015521 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Sulfamerazine |
|---|
| Description | Sulfamerazine is only found in individuals that have used or taken this drug.It is a sulfanilamide that is used as an antibacterial agent. [PubChem]Sulfamerazine is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthetase (dihydrofolate synthetase). Sulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA. |
|---|
| Structure | CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1 InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15) |
|---|
| Synonyms | | Value | Source |
|---|
| (p-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin | ChEBI | | 2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine | ChEBI | | 2-(p-Aminobenzolsulfonamido)-4-methylpyrimidine | ChEBI | | 2-(Sulfanilamido)-4-methylpyrimidine | ChEBI | | 2-Sulfa-4-methylpyrimidine | ChEBI | | 4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide | ChEBI | | N-(4-Methyl-2-pyrimidyl)sulfanilamide | ChEBI | | N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide | ChEBI | | Sulfamerazina | ChEBI | | Sulfamerazinum | ChEBI | | Sulfamethyldiazine | ChEBI | | Sulphamerazine | ChEBI | | (p-Aminobenzolsulphonyl)-2-amino-4-methylpyrimidin | Generator | | 2-(4-Aminobenzenesulphonamido)-4-methylpyrimidine | Generator | | 2-(p-Aminobenzolsulphonamido)-4-methylpyrimidine | Generator | | 2-(Sulphanilamido)-4-methylpyrimidine | Generator | | 2-Sulpha-4-methylpyrimidine | Generator | | 4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulphonamide | Generator | | N-(4-Methyl-2-pyrimidyl)sulphanilamide | Generator | | N(1)-(4-Methyl-2-pyrimidinyl)sulphanilamide | Generator | | Sulphamerazina | Generator | | Sulphamerazinum | Generator | | Sulphamethyldiazine | Generator | | Sulfamerazine veyx brand | HMDB | | Trimetox | HMDB | | Veyx brand OF sulfamerazine | HMDB | | Methylsulfadiazine | HMDB | | Mebacid | HMDB |
|
|---|
| Chemical Formula | C11H12N4O2S |
|---|
| Average Molecular Weight | 264.304 |
|---|
| Monoisotopic Molecular Weight | 264.068096338 |
|---|
| IUPAC Name | 4-amino-N-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide |
|---|
| Traditional Name | sulfamerazine |
|---|
| CAS Registry Number | 127-79-7 |
|---|
| SMILES | CC1=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC=C1 |
|---|
| InChI Identifier | InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15) |
|---|
| InChI Key | QPPBRPIAZZHUNT-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzenesulfonamides |
|---|
| Direct Parent | Aminobenzenesulfonamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aminobenzenesulfonamide
- Benzenesulfonyl group
- Aniline or substituted anilines
- Pyrimidine
- Organosulfonic acid amide
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Heteroaromatic compound
- Aminosulfonyl compound
- Sulfonyl
- Azacycle
- Organoheterocyclic compound
- Amine
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Primary amine
- Organosulfur compound
- Organonitrogen compound
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 236 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.3 g/L | Not Available | | LogP | 0.14 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.79 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.8885 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.06 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 617.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 232.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 80.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 156.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 41.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 237.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 302.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 110.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 619.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 45.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 812.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 192.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 208.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 411.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 247.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 295.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Sulfamerazine,1TMS,isomer #1 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=N1 | 2778.7 | Semi standard non polar | 33892256 | | Sulfamerazine,1TMS,isomer #1 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=N1 | 2462.0 | Standard non polar | 33892256 | | Sulfamerazine,1TMS,isomer #1 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=N1 | 3726.0 | Standard polar | 33892256 | | Sulfamerazine,1TMS,isomer #2 | CC1=CC=NC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=N1 | 2543.6 | Semi standard non polar | 33892256 | | Sulfamerazine,1TMS,isomer #2 | CC1=CC=NC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=N1 | 2419.7 | Standard non polar | 33892256 | | Sulfamerazine,1TMS,isomer #2 | CC1=CC=NC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=N1 | 3876.8 | Standard polar | 33892256 | | Sulfamerazine,2TMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=N1 | 2550.1 | Semi standard non polar | 33892256 | | Sulfamerazine,2TMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=N1 | 2537.0 | Standard non polar | 33892256 | | Sulfamerazine,2TMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C)C=C2)=N1 | 3399.2 | Standard polar | 33892256 | | Sulfamerazine,2TMS,isomer #2 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=N1 | 2573.3 | Semi standard non polar | 33892256 | | Sulfamerazine,2TMS,isomer #2 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=N1 | 2552.2 | Standard non polar | 33892256 | | Sulfamerazine,2TMS,isomer #2 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=N1 | 3523.6 | Standard polar | 33892256 | | Sulfamerazine,3TMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=N1 | 2437.9 | Semi standard non polar | 33892256 | | Sulfamerazine,3TMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=N1 | 2655.3 | Standard non polar | 33892256 | | Sulfamerazine,3TMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C2)=N1 | 3246.1 | Standard polar | 33892256 | | Sulfamerazine,1TBDMS,isomer #1 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=N1 | 3005.9 | Semi standard non polar | 33892256 | | Sulfamerazine,1TBDMS,isomer #1 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=N1 | 2684.6 | Standard non polar | 33892256 | | Sulfamerazine,1TBDMS,isomer #1 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=N1 | 3768.3 | Standard polar | 33892256 | | Sulfamerazine,1TBDMS,isomer #2 | CC1=CC=NC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=N1 | 2793.4 | Semi standard non polar | 33892256 | | Sulfamerazine,1TBDMS,isomer #2 | CC1=CC=NC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=N1 | 2638.0 | Standard non polar | 33892256 | | Sulfamerazine,1TBDMS,isomer #2 | CC1=CC=NC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N)C=C2)=N1 | 3854.4 | Standard polar | 33892256 | | Sulfamerazine,2TBDMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=N1 | 3004.0 | Semi standard non polar | 33892256 | | Sulfamerazine,2TBDMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=N1 | 2984.6 | Standard non polar | 33892256 | | Sulfamerazine,2TBDMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N[Si](C)(C)C(C)(C)C)C=C2)=N1 | 3475.9 | Standard polar | 33892256 | | Sulfamerazine,2TBDMS,isomer #2 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=N1 | 3094.2 | Semi standard non polar | 33892256 | | Sulfamerazine,2TBDMS,isomer #2 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=N1 | 2980.8 | Standard non polar | 33892256 | | Sulfamerazine,2TBDMS,isomer #2 | CC1=CC=NC(NS(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=N1 | 3555.3 | Standard polar | 33892256 | | Sulfamerazine,3TBDMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=N1 | 3149.5 | Semi standard non polar | 33892256 | | Sulfamerazine,3TBDMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=N1 | 3338.5 | Standard non polar | 33892256 | | Sulfamerazine,3TBDMS,isomer #1 | CC1=CC=NC(N([Si](C)(C)C(C)(C)C)S(=O)(=O)C2=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C2)=N1 | 3398.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Sulfamerazine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9630000000-7f08d04a103b7e16f126 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Sulfamerazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfamerazine LC-ESI-qTof , Positive-QTOF | splash10-0bt9-4900000000-1429f19666bf05cae962 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfamerazine LC-ESI-QTOF , positive-QTOF | splash10-0aou-1920000000-06a82249586c8821f9d3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfamerazine , positive-QTOF | splash10-0bt9-4900000000-1429f19666bf05cae962 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfamerazine -1V, Positive-QTOF | splash10-0aou-1920000000-418893a0c51582391ad4 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 10V, Positive-QTOF | splash10-014i-0190000000-74f76987a0c498d6bca1 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 20V, Positive-QTOF | splash10-066r-2960000000-fe211aa71f3a8480b97c | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 40V, Positive-QTOF | splash10-00mo-9100000000-7b53bc2852347d4eb65a | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 10V, Negative-QTOF | splash10-03di-0090000000-c8b827438334ef9362a1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 20V, Negative-QTOF | splash10-03dj-1590000000-abc72f9a326e9106f00f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 40V, Negative-QTOF | splash10-0006-9400000000-adca0ea9c658e9952d5a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 10V, Positive-QTOF | splash10-014i-0090000000-d2eef97caf4d75ad8466 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 20V, Positive-QTOF | splash10-052f-9430000000-d161431499729de125e0 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 40V, Positive-QTOF | splash10-014l-9000000000-246c8431b9069be15277 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 10V, Negative-QTOF | splash10-03di-0090000000-961f60caf9f0b5d9c607 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 20V, Negative-QTOF | splash10-03di-1290000000-fff5d1edd43fea6c5e0b | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfamerazine 40V, Negative-QTOF | splash10-014l-9200000000-652240a00ecd796e0b7b | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|